IMCNYESO
UNII C416JC9CX0

Substance Identification & Data

This profile provides standardized clinical and technical data for Imcnyeso, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C416JC9CX0.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
C416JC9CX0
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
IMCNYESO
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Imcnyeso. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ANTI-NY-ESO1/LAGE-1A TCR/SCFV ANTI-CD3 IMCNYESO
BISPECIFIC NY-ESO-1- AND LAGE-1A-SPECIFIC TCR/ANTI-CD3
HLA- A*0201-RESTRICTED NY-ESO-1- AND LAGE-1A-SPECIFIC SOLUBLE TCR/ANTI-CD3 BISPECIFIC MOLECULE

Technical Codes

IMCNYESO